Abstract
We develop a generalized SEIRD model considering social distancing measures to describe the spread of COVID-19 with applications in Brazil. We assume uncertain scenarios with limited testing capacity, lack of reliable data, under-reporting of cases, and restricted testing policy. We developed a Bayesian framework for the identification of model parameters and uncertainty quantification of the model outcomes. A sensitivity analysis is performed to identify the most significant parameters on either the cumulative numbers of confirmed and death, or the effective reproduction number. We show the model parameter related to social distancing measures is one of the most influential. Different relaxation strategies of social distancing measures are then investigated to determine which strategies are viable and less hazardous to the population. The considered scenario of abrupt social distancing relaxation implemented after the occurrence of the peak of positively diagnosed cases can prolong the epidemic, with a significant increase of the projected numbers of confirmed and death cases. A worse scenario occur if the social distancing relaxation policy is implemented before evidence of the epidemiological control, indicating the importance of the proper choice of when to start relaxing social distancing measures. The employed approach and subsequent analysis applied over the Brazilian scenarios may be used to other locations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ACMR, LA, and JVOS would like to thank the support through CNPq projects 132591/2014-6, 301327/2020-3, and 166171/2018-2. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Finance Code 001.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Do not apply.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
†† The authors declare no competing interest.
New version with updated data and restructured text.
Data Availability
All related code and data are available at Zenodo.